AUNAHealthcare · Medical Care FacilitiesThe 7 Wall Street analysts covering Auna SA hold a median 12-month price target of $6.9 — +49.0% from the last close. Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 62 of 100 as at 4 Nov 2026 — in the upper half.
Consensus tells you what everyone already believes. The model scores Auna SA on its factor families — the same systematic rank behind the Ticker Nerd portfolio.
Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested
Value (96): The shares cost little relative to the profits and assets behind them — which can mean the market is too gloomy, or that the business really is in trouble.
Issuance (34): The company has been issuing shares or taking on financing, diluting existing holders.
Built and run by Aslam Ghouse, an ex-Goldman Sachs systematic trader with 15+ years in markets.
The bullish and bearish analyst opinions on AUNA, reported as data — targets and ratings, the market's view beside the model's.
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
Data provided by Twelve Data
The green dot is the last close — the median target sits +49.0% from it.
| Date | Firm | Action | Rating | Target |
|---|---|---|---|---|
| 26 May 2026 | JP Morgan | Maintains | Neutral | $6.00 → $5.00 |
| 26 May 2026 | JP Morgan | Maintains | Neutral | — |
| 16 Jan 2026 | Jefferies | Initiates | Buy | — |
| 18 Nov 2025 | JP Morgan | Downgrade | Neutral | — |
| 11 Feb 2025 | JP Morgan | Maintains | Overweight | — |
| 20 Sept 2024 | JP Morgan | Maintains | Overweight | — |
| 20 Aug 2024 | JP Morgan | Maintains | Overweight | — |
| 23 Apr 2024 | HSBC | Initiates | Buy | — |
| 16 Apr 2024 | Citigroup | Initiates | Buy | — |
| 16 Apr 2024 | JP Morgan | Initiates | Overweight | — |
| 16 Apr 2024 | Morgan Stanley | Initiates | Overweight | — |
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
AUNA appears in the Radar on the weeks it earns a place.
AI cloud capacity
MSFTAMZNGOOGLORCL
AI chips
NVDAAVGOAMDMU
AI networking and serversIn full
ANETDELLLITECRDO
Data centre power
VRTCEGGEVVST
Both lines are total return — dividends reinvested — so the comparison is honest on both sides.
Over the twelve months to 4 Nov 2026, Auna SA returned −17.3% against +14.8% for the S&P 500, dividends included.
Download this chart as an image — free to reuse; link this page as the source.
Data provided by Twelve Data
Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.
A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.
Cheaper than 9% of US stocks
Cheaper than 96% of US stocks
Cheaper than 79% of US stocks
Cheaper than 53% of US stocks
Higher than 60% of US stocks
Higher than 8% of US stocks
Higher than 43% of US stocks
Higher than 70% of US stocks
Higher than 48% of US stocks
Higher than 47% of US stocks
Higher than 78% of US stocks
Higher than 1% of US dividend payers
Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.
The headline figures, each with its date. Every row carries its own link — cite it straight from here.
Auna SA has a market value of $334.0M and an enterprise value of $1.1B.
Revenue in the twelve months to 30 June 2026: $4.7B. The latest quarter grew 13.2% year on year.
Net income over the same four quarters: $31.1M, a 0.7% net margin.
Diluted earnings per share, trailing twelve months: $0.22.
Free cash flow in the twelve months to 30 June 2026: $725.2M.
Auna SA spent $0.0 on dividends in the twelve months to 30 June 2026.
Trailing P/E: 77.5×; forward P/E: 4.3× — the forward figure prices analyst consensus estimates, not reported earnings.
Forward dividend yield: 0.00%, paying out 0% of earnings.
Auna SA employs 14,796 people — $315K of revenue per employee.
Data provided by Twelve Data
The nearest names by industry and size, scored by the same model — like for like.
Look up any of the roughly 4,600 stocks we score.
The rank is the raw material. Whether the rules would actually own Auna SA — and when they’d sell — is the membership. See the Ticker Nerd 20 →
At its 2026 Investor Day, Auna outlined plans to expand its integrated healthcare platform across Latin America. It also lowered expectations for adjusted EBITDA growth this year amid reimbursement and contracting pressures in Colombia.
Why it matters — AUNA watchers may note the Colombia pressures and revised EBITDA growth expectations alongside the company's regional expansion strategy.
Seeking Alpha published a transcript of Auna S.A.’s Analyst/Investor Day.
Why it matters — The transcript provides AUNA watchers with a record of the company’s remarks at its Analyst/Investor Day.
Auna announced a preliminary update to its full-year 2026 outlook. The company expects revenue growth to be in line with guidance communicated earlier in the year, citing favorable volume and specialty service trends in third-quarter operating KPIs.
Why it matters — AUNA watchers may note the company’s preliminary confirmation that it expects to meet its previously communicated revenue-growth guidance for 2026.
Seeking Alpha reports that Auna’s preliminary Q3 results showed hospital activity strengthening across Peru, Colombia and Mexico, with surgeries rising 11.7% year over year. The article cites higher occupancy, oncology-service expansion and contractual price adjustments as factors supporting its expectation of H2 2026 EBITDA margin recovery.
Why it matters — The reported volume gains and potential margin recovery, alongside improving free cash flow and the valuation discussed in the article, are relevant to investors monitoring Auna’s operating performance and debt reduction.
Auna reported select operating metrics for the third quarter ended September 30, 2026, as part of its quarterly publication of key performance indicators. The excerpt does not provide specific metric values.
Why it matters — AUNA watchers may track the quarterly operating indicators for information about the company's healthcare services operations.
The 7 Wall Street analysts covering Auna SA have a median 12-month price target of $6.9, with estimates ranging from $5 to $9. These are third-party analyst estimates, not Ticker Nerd forecasts, and they are frequently wrong.
Of the 7 analysts covering Auna SA, 5 rate it a Buy, 2 a Hold and 0 a Sell. Ticker Nerd's systematic factor model ranks Auna SA 62 out of 100 across roughly 4,600 US stocks as at 4 Nov 2026. None of this is personal advice — it does not consider your circumstances.
As at 4 Nov 2026, Auna SA ranks 62 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Value (96 of 100).
No one can know that. What the data says: the median 12-month target from 7 analysts implies +49.0% from the last close, and Ticker Nerd's factor model ranks Auna SA 62 out of 100 as at 4 Nov 2026. Analyst targets are third-party estimates and frequently wrong; none of this is personal advice.
No analyst covering Auna SA publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for AUNA are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $5 to $9 over the next 12 months.
Auna SA returned -17.3% over the 12 months to 4 Nov 2026, with dividends reinvested. Past performance does not indicate future returns.
Auna S.A. Class A Ordinary Shares represent ownership in Auna S.A., a healthcare services company focused on delivering integrated medical care across Latin America.
The most recent item we track (MarketBeat, 23 Oct 2026): "Auna Investor Day: Colombia Pressure Prompts 2026 EBITDA Growth Reset". At its 2026 Investor Day, Auna outlined plans to expand its integrated healthcare platform across Latin America. It also lowered expectations for adjusted EBITDA growth this year amid reimbursement and contracting pressures in Colombia.
Auna S.A. Class A Ordinary Shares represent ownership in Auna S.A., a healthcare services company focused on delivering integrated medical care across Latin America. Auna operates hospitals and clinics in Mexico, Peru, and Colombia, supported by a network that includes outpatient centers, diagnostic services, and specialty care facilities. The company also offers prepaid healthcare plans in Peru, dental and vision insurance in Mexico, and oncology-related plans, while complementing its services with medicine sales. Through these businesses, Auna serves individuals and families seeking coordinated access to medical treatment, preventive care, and specialized health coverage. Headquartered in Luxembourg, Auna plays a role in the region’s healthcare market by combining provider services with insurance-linked products and disease-focused care offerings.
CEO Mr. Jesús Antonio Zamora Leon · 14,796 employees · Luxembourg · https://www.aunainvestors.com
